Literature DB >> 19601724

Drug interactions.

Alan Boobis1, Jean-Baptiste Watelet, Rhys Whomsley, Margherita Strolin Benedetti, Pascal Demoly, Keith Tipton.   

Abstract

Drugs for allergy are often taken in combination with other drugs, either to treat allergy or other conditions. In common with many pharmaceuticals, most such drugs are subject to metabolism by P450 enzymes and to transmembrane transport. This gives rise to considerable potential for drug-drug interactions, to which must be added consideration of drug-diet interactions. The potential for metabolism-based drug interactions is increasingly being taken into account during drug development, using a variety of in silico and in vitro approaches. Prediction of transporter-based interactions is not as advanced. The clinical importance of a drug interaction will depend upon a number of factors, and it is important to address concerns quantitatively, taking into account the therapeutic index of the compound.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19601724     DOI: 10.1080/10837450902891550

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  10 in total

1.  Exposure of LS-180 cells to drugs of diverse physicochemical and therapeutic properties up-regulates P-glycoprotein expression and activity.

Authors:  Alaa H Abuznait; Shawn G Patrick; Amal Kaddoumi
Journal:  J Pharm Pharm Sci       Date:  2011       Impact factor: 2.327

2.  From caffeine to fish waste: amine compounds present in food and drugs and their interactions with primary amine oxidase.

Authors:  Aldo Olivieri; Daniel Rico; Zhied Khiari; Gary Henehan; Jeff O'Sullivan; Keith Tipton
Journal:  J Neural Transm (Vienna)       Date:  2011-03-04       Impact factor: 3.575

Review 3.  Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions.

Authors:  Hong-Wu Shen; Xi-Ling Jiang; Jerrold C Winter; Ai-Ming Yu
Journal:  Curr Drug Metab       Date:  2010-10       Impact factor: 3.731

4.  Discovering drug-drug interactions: a text-mining and reasoning approach based on properties of drug metabolism.

Authors:  Luis Tari; Saadat Anwar; Shanshan Liang; James Cai; Chitta Baral
Journal:  Bioinformatics       Date:  2010-09-15       Impact factor: 6.937

5.  The use of isomeric testosterone dimers to explore allosteric effects in substrate binding to cytochrome P450 CYP3A4.

Authors:  Ilia G Denisov; Piotr J Mak; Yelena V Grinkova; Dominic Bastien; Gervais Bérubé; Stephen G Sligar; James R Kincaid
Journal:  J Inorg Biochem       Date:  2015-12-31       Impact factor: 4.155

Review 6.  Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation.

Authors:  Santosh Kumar
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-02       Impact factor: 4.481

7.  Expression of cytochrome P450 isozyme transcripts and activities in human livers.

Authors:  Jie Liu; Yuan-Fu Lu; J Christopher Corton; Curtis D Klaassen
Journal:  Xenobiotica       Date:  2020-12-28       Impact factor: 1.908

8.  Reliably assessing the electronic structure of cytochrome P450 on today's classical computers and tomorrow's quantum computers.

Authors:  Joshua J Goings; Alec White; Joonho Lee; Christofer S Tautermann; Matthias Degroote; Craig Gidney; Toru Shiozaki; Ryan Babbush; Nicholas C Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-12       Impact factor: 12.779

9.  A Guidance for Concomitant Drug Reconciliation Prior to Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults.

Authors:  Beth Apsel Winger; Susie E Long; Jordan Brooks; Ashish O Gupta; Christopher C Dvorak; Janel Renee Long-Boyle
Journal:  Front Pediatr       Date:  2021-07-19       Impact factor: 3.418

10.  Statistical and Ontological Analysis of Adverse Events Associated with Monovalent and Combination Vaccines against Hepatitis A and B Diseases.

Authors:  Jiangan Xie; Lili Zhao; Shangbo Zhou; Yongqun He
Journal:  Sci Rep       Date:  2016-10-03       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.